Analyst firms · Raymond James · ACHC
Raymond James ACHC price target and rating history
Acadia Healthcare Company Inc. (ACHC) · Health Care
Raymond James rates Acadia Healthcare Company Inc. (ACHC) Outperform with a $39 price target, as of its latest action on Sep 28, 2026. It has published 3 rating actions on ACHC since August 2025, including 1 upgrade and 2 downgrades. Across 4 firms with a ACHC price target in the last 12 months, the median target is $22. Raymond James's $39 is 77% above that.
- Current rating
- Outperform
- Price target
- $39
- Median target, all firms
- $22
- Actions on ACHC
- 3
Raymond James price target on ACHC
Every Raymond James rating on ACHC
- Sep 28, 2026
- May 4, 2026
- Aug 14, 2025
How other firms rate ACHC
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Raymond James | Outperform | $39 | Sep 28, 2026 |
| Jefferies | Buy | $30 | Jun 3, 2026 |
| Leerink Partners | Market Perform | $14 | Dec 3, 2025 |
| BofA Securities | Underperform | $13 | Dec 3, 2025 |
Questions about Raymond James and ACHC
- What is Raymond James's price target for ACHC?
- Raymond James's latest stated price target for Acadia Healthcare Company Inc. (ACHC) is $39, from its action on Sep 28, 2026.
- What is Raymond James's rating on ACHC?
- Raymond James rates ACHC Outperform, a bullish rating, as of Sep 28, 2026.
- When did Raymond James last change its view on ACHC?
- On Sep 28, 2026, Raymond James downgrades to Outperform from Strong Buy, price target $39.
- How does Raymond James's ACHC target compare with other analysts?
- Across 4 firms with a ACHC price target in the last 12 months, the median target is $22. Raymond James's $39 is 77% above that.
More ACHC rating histories
All Raymond James ratingsACHC news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.